DE69418715D1 - Erythromycinderivate - Google Patents

Erythromycinderivate

Info

Publication number
DE69418715D1
DE69418715D1 DE69418715T DE69418715T DE69418715D1 DE 69418715 D1 DE69418715 D1 DE 69418715D1 DE 69418715 T DE69418715 T DE 69418715T DE 69418715 T DE69418715 T DE 69418715T DE 69418715 D1 DE69418715 D1 DE 69418715D1
Authority
DE
Germany
Prior art keywords
image
erythromycinderivate
isting
ch2ch2
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69418715T
Other languages
English (en)
Other versions
DE69418715T2 (de
Inventor
Carla Edwards
Paul A Lartey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69418715D1 publication Critical patent/DE69418715D1/de
Publication of DE69418715T2 publication Critical patent/DE69418715T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE69418715T 1993-07-06 1994-07-06 Erythromycinderivate Expired - Fee Related DE69418715T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/087,547 US5393743A (en) 1993-07-06 1993-07-06 Erythromycin derivatives
PCT/US1994/007575 WO1995001794A1 (en) 1993-07-06 1994-07-06 Erythromycin derivatives

Publications (2)

Publication Number Publication Date
DE69418715D1 true DE69418715D1 (en) 1999-07-01
DE69418715T2 DE69418715T2 (de) 1999-12-16

Family

ID=22205823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418715T Expired - Fee Related DE69418715T2 (de) 1993-07-06 1994-07-06 Erythromycinderivate

Country Status (10)

Country Link
US (1) US5393743A (de)
EP (1) EP0707482B1 (de)
JP (1) JPH08512324A (de)
AT (1) ATE180406T1 (de)
CA (1) CA2165078A1 (de)
DE (1) DE69418715T2 (de)
DK (1) DK0707482T3 (de)
ES (1) ES2133567T3 (de)
GR (1) GR3030692T3 (de)
WO (1) WO1995001794A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
US11420995B2 (en) 2017-03-03 2022-08-23 Synovo Gmbh Anti-infective and anti-inflammatory compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1195299B (it) * 1981-11-27 1988-10-12 Pierrel Spa Procedimento chimico di sintesi per la preparazione di antibiotici macrolidici
IT1163796B (it) * 1983-07-18 1987-04-08 Pierrel Spa Procedimento per la preparazione di (8s)-8-fluoroeritromicina

Also Published As

Publication number Publication date
DK0707482T3 (da) 1999-12-06
DE69418715T2 (de) 1999-12-16
EP0707482A1 (de) 1996-04-24
ATE180406T1 (de) 1999-06-15
ES2133567T3 (es) 1999-09-16
EP0707482B1 (de) 1999-05-26
GR3030692T3 (en) 1999-11-30
CA2165078A1 (en) 1995-01-19
WO1995001794A1 (en) 1995-01-19
EP0707482A4 (de) 1997-03-19
US5393743A (en) 1995-02-28
JPH08512324A (ja) 1996-12-24

Similar Documents

Publication Publication Date Title
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
DE69705300T2 (de) Cyclopropylalkansäurederivate
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
DE69317877D1 (en) 4''-deoxyerythromycinderivate
HU9401584D0 (en) Preparation of substituted piperidines
TW252979B (de)
NZ240441A (en) Thiazol- or thiadiazol-substituted 7-acyl-3-substituted carbamoyloxy cephem derivatives and antibacterial compositions thereof; cephem intermediates
DE69418715D1 (en) Erythromycinderivate
GR3030506T3 (en) 1-azaadamantane derivatives as 5-ht agonists or antagonists.
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
IL107232A0 (en) 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
PL313708A1 (en) Novel anthracyclin disaccharides, method of obtaining and preparation containing them
IL99369A0 (en) Pharmaceutical compositions containing substituted 2-cyclohexene derivatives
HUT60495A (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee